In vitro resistance to thrombin-induced platelet microbicidal protein among clinical bacteremic isolates of Staphylococcus aureus correlates with an endovascular infectious source
- PMID: 9835510
- PMCID: PMC106018
- DOI: 10.1128/AAC.42.12.3169
In vitro resistance to thrombin-induced platelet microbicidal protein among clinical bacteremic isolates of Staphylococcus aureus correlates with an endovascular infectious source
Abstract
Platelet microbicidal proteins (PMPs), small cationic peptides released at sites of endovascular damage, kill common bloodstream pathogens in vitro. Our group previously showed that in vitro resistance of clinical staphylococcal and viridans group streptococcal bacteremic strains to PMPs correlated with the diagnosis of infective endocarditis (IE) (Wu et al., Antimicrob. Agents Chemother. 38:729-732, 1994). However, that study was limited by (i) the small number of Staphylococcus aureus isolates from IE patients, (ii) the retrospective nature of the case definitions, and (iii) the diverse geographic sources of strains. The present study evaluated the in vitro PMP susceptibility phenotype of a large number of staphylococcemic isolates (n = 60), collected at a single medical center and categorized by defined and validated clinical criteria. A significantly higher proportion of staphylococcemic strains from patients with IE was PMP resistant in vitro than the proportion of strains from patients with soft tissue sepsis (83% and 33%, respectively; P < 0.01). Moreover, the levels of PMP resistance (mean percent survival of strains after 2-h exposure to PMP in vitro) were significantly higher for isolates from patients with IE and with vascular catheter sepsis than for strains from patients with abscess sepsis (P < 0.005 and P < 0.01, respectively). These data further support the concept that bloodstream pathogens that exhibit innate or acquired PMP resistance have a survival advantage with respect to either the induction or progression of endovascular infections.
Figures

Similar articles
-
In vitro resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein is associated with alterations in cytoplasmic membrane fluidity.Infect Immun. 2000 Jun;68(6):3548-53. doi: 10.1128/IAI.68.6.3548-3553.2000. Infect Immun. 2000. PMID: 10816510 Free PMC article.
-
In vitro resistance to thrombin-induced platelet microbicidal protein in isolates of Staphylococcus aureus from endocarditis patients correlates with an intravascular device source.J Infect Dis. 2000 Oct;182(4):1251-4. doi: 10.1086/315812. Epub 2000 Sep 8. J Infect Dis. 2000. PMID: 10979928
-
In vitro resistance to platelet microbicidal protein correlates with endocarditis source among bacteremic staphylococcal and streptococcal isolates.Antimicrob Agents Chemother. 1994 Apr;38(4):729-32. doi: 10.1128/AAC.38.4.729. Antimicrob Agents Chemother. 1994. PMID: 8031037 Free PMC article.
-
[Staphylococcus aureus sepsis in hospitalized non neutropenic patients: retrospective clinical and microbiological analysis].Ann Ital Med Int. 2002 Jul-Sep;17(3):166-72. Ann Ital Med Int. 2002. PMID: 12402664 Review. Italian.
-
Significance of Staphylococcus lugdunensis bacteremia: report of 28 cases and review of the literature.Infection. 2008 Aug;36(4):314-21. doi: 10.1007/s15010-008-7287-9. Epub 2008 Jul 21. Infection. 2008. PMID: 18648747 Review.
Cited by
-
Combinatorial phenotypic signatures distinguish persistent from resolving methicillin-resistant Staphylococcus aureus bacteremia isolates.Antimicrob Agents Chemother. 2011 Feb;55(2):575-82. doi: 10.1128/AAC.01028-10. Epub 2010 Nov 22. Antimicrob Agents Chemother. 2011. PMID: 21098242 Free PMC article. Clinical Trial.
-
In vitro resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein is associated with alterations in cytoplasmic membrane fluidity.Infect Immun. 2000 Jun;68(6):3548-53. doi: 10.1128/IAI.68.6.3548-3553.2000. Infect Immun. 2000. PMID: 10816510 Free PMC article.
-
Staphylococcus aureus, Platelets, and the Heart.Curr Infect Dis Rep. 2000 Aug;2(4):281-298. doi: 10.1007/s11908-000-0005-0. Curr Infect Dis Rep. 2000. PMID: 11095867
-
DltABCD- and MprF-mediated cell envelope modifications of Staphylococcus aureus confer resistance to platelet microbicidal proteins and contribute to virulence in a rabbit endocarditis model.Infect Immun. 2005 Dec;73(12):8033-8. doi: 10.1128/IAI.73.12.8033-8038.2005. Infect Immun. 2005. PMID: 16299297 Free PMC article.
-
Interleukin 1alpha increases the susceptibility of rabbits to experimental viridans streptococcal endocarditis.Infect Immun. 2006 Feb;74(2):947-52. doi: 10.1128/IAI.74.2.947-952.2006. Infect Immun. 2006. PMID: 16428739 Free PMC article.
References
-
- Azizi N, Li C, Shen A J, Bayer A S, Yeaman M R. Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C: American Society for Microbiology; 1996. Staphylococcus aureus elicits release of platelet microbicidal proteins in vitro, abstr. G54; p. 153.
-
- Cheng D, Bayer A S, Yeaman M R, Corey G R, McClelland R S, Harrell E, Fowler V G. Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C: American Society for Microbiology; 1998. In vitro resistance to thrombin-induced platelet microbicidal protein (tPMP) among Staphylococcus aureus bacteremic (SAB) isolates correlates with endovascular infection source, abstr. B-20; p. 50. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical